Select a Region North America

Ensure Market Access

Integrated Market Access Strategies

End-to-End Capabilities

Market Access is a complicated ecosystem of decisions and strategies intended to efficiently place pharmaceutical products in the hands of patients.

These complexities are increasing due to:

  • The robust pipeline of high-science brands
  • Payor challenges with covering innovative therapies (DTx, oncology and CGT)
  • Traditional pricing strategies that are not reflective of the potential for cures vs. chronic therapies.

In addition, highly desired, value-based contracts are hard to operationalize in a standardized and efficient way and patients are becoming more tech advanced than pharma innovators – all of these considerations creating new complexities in delivering an exceptional patient experience

For EVERSANA, Market Access is broader than just payer engagement; it’s getting the right treatment to the right patient at the right time in a consistent and sustained manner, and at an affordable price. We know how to balance stakeholder, provider and patient needs to develop impactful market access strategies and execution –  which is critical now more than ever.

Powering Market Access with Data & Analytics

Powered by ACTICS by EVERSANA, our artificial intelligence-powered & machine learning-enabled platform, we help clients drive market access success through:

  • The ability to predict and quantify gross-to-net for contracting market access, rebates, formulary position and optimal launch dynamics, as well as determine opportunities and metrics for value-based contracting.
  • Predict, monitor, measure and optimize pull-through, sales force, and account management opportunities and utilization.
  • Assess market entry and competitive contract dynamics and opportunities.
  • Fold in payer and IDN influence into overall KOL mapping for complete view of access control.

EVERSANA’s suite of comprehensive market access capabilities include:

  • Global Pricing & Insights

    Global Pricing & Insights

    The intelligence you need to assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.

    자세히 알아보기
  • Market Access Strategy & Stakeholder Engagement

    Market Access Strategy & Stakeholder Engagement

    Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.

    자세히 알아보기
  • Global Channel & 3PL

    Global Channel & 3PL

    Distribution from Day 1 including special logistics for regenerative medicine.

    자세히 알아보기
  • Specialty & Direct-to-Patient Distribution

    Specialty & Direct-to-Patient Distribution

    Get therapies to patients quickly and effectively. We manage inventory, payer relationships, cash flow and wraparound patient service needs.

    자세히 알아보기
  • Affordability Programs

    Affordability Programs

    Help your patients secure treatments by offering options to manage cost.

    자세히 알아보기
  • Agency Services

    Agency Services

    World-class creative and digital teams with deep market access, payer, and healthcare communications expertise,

    자세히 알아보기

Employ and Integrated Market Access Strategy to Deliver Brand Success

The pharma/life sciences pipeline is vibrant, with ongoing innovation bringing new hope to patients and providers across many therapeutic areas. Against the backdrop of rapid scientific advancement in and precision medicine and targeted therapies in primary and specialty care as well as rare and orphan diseases, today’s medicines continue to create immense complexity for all stakeholders — patients, providers and payers.

document download